Stocks expected to have increasing option volume: LLY SCS DRI RAD
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Eli Lilly (LLY) PT Raised to 'Street High' $300 at Cantor Fitzgerald
June 24, 2021 9:10 AM EDTCantor Fitzgerald analyst Louise Chen raised the price target on Eli Lilly (NYSE: LLY) to a "Street High" $300.00 (from $245.00) while maintaining an Overweight rating after the FDA has granted its Alzheimer's disease drug donanemab Breakthrough Therapy Designation.
... MoreEli Lilly (LLY) PT Raised to $250 at Mizuho Securities as Donanemab Granted Breakthrough Therapy Designation
June 24, 2021 8:47 AM EDTMizuho Securities analyst Vamil Divan raised the price target on Eli Lilly (NYSE: LLY) to $250.00 (from $217.00) while maintaining a Buy rating.
The analyst commented, "Lilly has answered one of the most pressing questions in our coverage, announcing the FDA has granted its Alzheimer's disease drug... More
